Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Comparer
Comparer des captures archivées
Cette vue met en évidence des différences de texte entre deux captures archivées. Elle n’interprète pas le sens et ne fournit pas de directives.
Changements descriptifs seulement
Cette comparaison met en évidence des changements de texte entre des captures archivées. Elle n’interprète pas le changement et ne fournit pas d’avis médical. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Besoin de citer cette comparaison? Voir /cite.
Capture précédente
Health concerns consultations - Canada.ca
18 avr. 2025
legacy-hc-2025-04-21
ID 236096
Capture suivante
Archived Health concerns consultations - Canada.ca
1 janv. 2026
hc-20260101
ID 404557
updated2 sections changed; 1 added; 3 removed
2 sections modifiées1 ajoutées3 retirées+2 / -20 lignesVariation: 14%
--- +++ @@ -1,4 +1,4 @@-Health concerns consultations+Archived Health concerns consultations Health Canada recognizes that one of the key challenges in governance today is meaningful public involvement in policy and programme development, service delivery, and legislative and regulatory initiatives. Canadians are better educated and informed than ever before, and they expect to have a say in public policy decision-making. On this page, you will find an overview of current public consultations in which you can take part, and you can find out about past consultations as well. What Information is Available This section provides information on consultation opportunities going on in the area of Health Concerns.@@ -60,29 +60,11 @@ Consultation - Proposal regarding the scheduling of AH-7921 and MT-45 under the Controlled Drugs and Substances Act and its Regulations-Consultation - Proposal regarding the scheduling of 2C-phenethylamines under the-Controlled Drugs and Substances Act-and its regulations-Notice of Pre-Consultation - Draft-Tamper-Resistant Properties of Drugs Regulation Consultation - Regulatory amendments regarding the salts of apomorphine, cyprenorphine, narcotine, papaverine, carbamethidine, oxpheneridine, ethoheptazine, metethoheptazine, metheptazine, dextromethorphan, dextrorphan, levallorphan, levargorphan and cyclazocine-Consultation - Proposed Regulations Amending Regulations under the-Controlled Drugs and Substances Act-with Respect to the Issuance of Licences and Permits Consultation - Regulatory Amendments Regarding Barbituric Acid, Naloxegol, Methylnaltrexone, Catha edulis Forsk, Cathine and Cathinone and the Salts of Nalmefene, Naloxone and Naltrexone-Order Amending the Schedule to the-Tobacco Act-2014-Notice of Proposed Order to amend the Schedule to the-Tobacco Act-Notice of Intent to Interested Parties: Tamper Resistance under the-Controlled Drugs and Substances Act-2013-Consultation on Health Canada's Review of the Industrial Hemp Framework 2004 Proposal for New Health-Related Information on Tobacco Product Labels - A Consultation Paper Page details-Date modified:-2025-02-27+2025-05-29